Sign in
SCHEDULE 13G/A

Statement of Beneficial Ownership

Eledon Pharmaceuticals, Inc. Filed Acc 0000921895-26-003175

Stakes reported in this filing

Reporting person Shares Of the class
BVF PARTNERS L P/IL 8,655,393 9.99%
BVF INC/IL 8,655,393 9.99%
LAMPERT MARK N 8,655,393 9.99%
BVF GP HOLDINGS LLC 8,235,295 9.5%
BIOTECHNOLOGY VALUE FUND L P 6,061,390 7.0%
BVF I GP LLC 6,061,390 7.0%
BIOTECHNOLOGY VALUE FUND II LP 2,173,905 2.6%
BVF II GP LLC 2,173,905 2.6%
Biotechnology Value Trading Fund OS LP 377,015 0.4%
BVF Partners OS Ltd. 377,015 0.4%

Members of a group can each report the same shares, so these rows overlap and don't add up.

Loading xslSCHEDULE_13G_X02/primary_doc.xml…